Trial · NCT03687814
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
Consecutive patients with Irritable Bowel Syndrome with Constipation (IBS-C) will be recruited from the outpatient clinics of the University of Michigan Health
- Status
- Recruiting
- Sponsor
- University of Michigan
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 78 participants (planned)
- Start
- Nov 8, 2018
- Primary completion
- January 2026
- Conditions
- Irritable Bowel Syndrome Characterized by Constipation
Summary
Consecutive patients with Irritable Bowel Syndrome with Constipation (IBS-C) will be recruited from the outpatient clinics of the University of Michigan Health System. Eligible patients will be asked to participate in a study that will test the efficacy the PEG 3350 + a diet low in fermentable oligo, di, monosaccharides, and polyols (FODMAP) vs. PEG 3350 plus sham diet. Blinding dietary advice trials is challenging and therefore the sham diet was based on the criteria set forth by Staudacher et al.
Interventions
- Low FODMAP diet/PEG 3350 Other
- sham diet/PEG 3350 Other
Locations
1 country: United States.
| Facility | City | Country |
|---|---|---|
| University of Michigan | Ann Arbor, Michigan | United States |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.